Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera Moura

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 1, 2022
Targeted liposomal doxorubicin/ceramides combinations: The importance to assess the nature of drug interaction beyond bulk tumor cellsAna Filipa Cruz, Nuno A Fonseca, Ana Rita Malheiro, et al.
Breast Cancer Research and Treatment|August 2, 2011
Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancerVera Moura, Manuela Lacerda, Paulo Figueiredo, et al.
International Journal of Pharmaceutics|May 24, 2012
Toward a siRNA-containing nanoparticle targeted to breast cancer cells and the tumor microenvironmentLígia C Gomes-da-Silva, Adriana O Santos, Luís M Bimbo, et al.
Cancers|July 2, 2021
The Enhanced Efficacy of Intracellular Delivery of Doxorubicin/C6-Ceramide Combination Mediated by the F3 Peptide/Nucleolin System Is Supported by the Downregulation of the PI3K/Akt PathwayAna F Cruz, Mariana B Caleiras, Nuno A Fonseca, et al.
Biomaterials|August 19, 2015
Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combinationNuno A Fonseca, Ana S Rodrigues, Paulo Rodrigues-Santos, et al.
Cancers|May 14, 2022
Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung CancerÂngela Valério-Fernandes, Nuno A Fonseca, Nélio Gonçalves, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 3, 2021
Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapyChiara Brignole, Veronica Bensa, Nuno A Fonseca, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 1, 2022
Targeted liposomal doxorubicin/ceramides combinations: The importance to assess the nature of drug interaction beyond bulk tumor cellsAna Filipa Cruz, Nuno A Fonseca, Ana Rita Malheiro, et al.
Breast Cancer Research and Treatment|August 2, 2011
Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancerVera Moura, Manuela Lacerda, Paulo Figueiredo, et al.
International Journal of Pharmaceutics|May 24, 2012
Toward a siRNA-containing nanoparticle targeted to breast cancer cells and the tumor microenvironmentLígia C Gomes-da-Silva, Adriana O Santos, Luís M Bimbo, et al.
Cancers|July 2, 2021
The Enhanced Efficacy of Intracellular Delivery of Doxorubicin/C6-Ceramide Combination Mediated by the F3 Peptide/Nucleolin System Is Supported by the Downregulation of the PI3K/Akt PathwayAna F Cruz, Mariana B Caleiras, Nuno A Fonseca, et al.
Biomaterials|August 19, 2015
Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combinationNuno A Fonseca, Ana S Rodrigues, Paulo Rodrigues-Santos, et al.
Cancers|May 14, 2022
Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung CancerÂngela Valério-Fernandes, Nuno A Fonseca, Nélio Gonçalves, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 3, 2021
Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapyChiara Brignole, Veronica Bensa, Nuno A Fonseca, et al.
Pageof 2